What is the primary focus of this international conference?

The conference focuses on international cooperation, health diplomacy, and policy, exploring their intricate connections in global health.

International Conference on International Cooperation, Health Diplomacy, and Policy

Name: International Conference on International Cooperation, Health Diplomacy, and Policy
Start: 2026-11-21T00:00:00Z
End: 2026-11-21T00:00:00Z
Location: Cairo

Nov 21, 2026Cairo, EgyptIn-person

Registration open

The International Conference on International Cooperation, Health Diplomacy, and Policy, scheduled to take place in Cairo, EGY, provides a crucial platform for exploring the complex interplay between global collaboration, public health strategies, and policy development. This event brings together experts and practitioners to discuss challenges and innovations in health diplomacy, emphasizing the role of international cooperation in addressing global health issues. Participants will delve into how diplomatic efforts can shape effective health policies and foster cross-border partnerships to improve health outcomes worldwide.

Committees & topics

World Health Organization
Health Diplomacy in International Relations · Global Cooperation for Pandemic Preparedness · The Role of the WHO in Health Diplomacy · Bilateral Health Agreements and Policies · Global Health Governance and HIV/AIDS · Health Diplomacy in the Fight Against HIV/AIDS · Multilateralism and the HIV/AIDS Response · Policy Advocacy for HIV/AIDS Prevention and Treatment

Why it matters

In an increasingly interconnected world, health challenges often transcend national borders, necessitating robust international cooperation and sophisticated health diplomacy. Events such as this conference are vital for dissecting the mechanisms through which countries can collectively respond to pandemics, manage health crises, and build resilient health systems. The discussions will likely touch upon the strategic importance of health in foreign policy, examining how nations leverage health initiatives to build trust, exert soft power, and achieve broader diplomatic objectives.

The insights generated from this conference are particularly relevant for understanding the evolving landscape of global health governance. As various actors—from states to non-governmental organizations—engage in health diplomacy, the need for coherent policy frameworks becomes paramount. This event offers a timely opportunity to assess current approaches and propose innovative solutions for more effective international health collaborations, especially in the context of emerging global health threats and disparities. The focus on policy implications underscores the practical application of diplomatic efforts in shaping tangible health outcomes.

How to prepare

Delegates preparing for this conference should focus on understanding the multifaceted nature of health diplomacy. A thorough review of frameworks related to global health security, international health regulations, and multilateral health initiatives would be beneficial. Consider how different national interests converge or diverge in the pursuit of global health objectives, and be prepared to discuss case studies where international cooperation has either succeeded or failed in addressing significant health challenges.

Effective participation will require an understanding of key stakeholders in global health, including international organizations, national health ministries, and non-state actors. Familiarity with concepts such as "hidden-stakeholders" and "engagement-strategies" will be crucial for navigating discussions on complex health policy issues. Participants should also be ready to analyze current geopolitical trends and their impact on health diplomacy, considering how political dynamics influence resource allocation, research collaboration, and equitable access to health interventions. Preparing specific policy recommendations or innovative partnership models relevant to the conference themes could also enhance engagement.

Country perspectives

Where the most-relevant 4 countries stand on the core issues in play. Click through for the full country profile.

Egypt

As the host nation, EGY is likely to emphasize regional health challenges and the importance of South-South cooperation in health diplomacy.

Role in topic

EGY, situated at a crossroads of continents, plays a significant role in regional health initiatives and often advocates for increased international support for public health infrastructure in developing nations. Its perspective will highlight the need for tailored health policies that address specific regional epidemiological patterns and socio-economic contexts.

United States

The USA will likely advocate for robust global health security frameworks and emphasize its contributions to international health funding and research.

Role in topic

The USA is a major donor and influencer in global health, often leading initiatives on disease eradication, vaccine development, and health system strengthening. Its perspective will focus on the strategic importance of health diplomacy for national security and global stability, promoting multilateral partnerships and evidence-based policy.

China

CHN is expected to highlight its Belt and Road Initiative's health component and its contributions to global health through medical aid and infrastructure development.

Role in topic

CHN has significantly expanded its health diplomacy, particularly through initiatives that integrate health cooperation with broader economic development. Its approach often emphasizes bilateral partnerships and the sharing of medical expertise and resources, particularly with countries in Africa and Asia.

Switzerland

CHE will likely stress its role as a hub for international organizations and its commitment to humanitarian health aid and neutral mediation in health crises.

Role in topic

As the host to numerous international health organizations, CHE plays a critical role in facilitating global health governance and humanitarian efforts. Its perspective often centers on promoting universal health coverage, ethical considerations in health policy, and the importance of neutral platforms for health diplomacy.

Topics & background

The background behind each topic and the actors that shape it.

World Health Organization

Health Diplomacy in International Relations

Health diplomacy emerged as a distinct field in the late 20th century, as cross-border disease threats, trade in medical goods, and humanitarian crises drew foreign ministries into matters once handled solely by health authorities. Landmark moments include the 1851 International Sanitary Conferences, the 1969 International Health Regulations, and the 2003 SARS outbreak, which exposed how rapidly pathogens move with globalized travel and how political secrecy can undermine collective security. Since then, states have increasingly used health cooperation as both a tool of soft power and a venue for negotiation on intellectual property, trade, and security. Contemporary health diplomacy operates across three intersecting tracks: core diplomacy (treaty negotiation at the World Health Assembly), multistakeholder diplomacy (engaging philanthropies, pharmaceutical firms, and NGOs), and informal diplomacy (scientific exchange and humanitarian assistance). Tensions persist between high-income states emphasizing biosecurity and intellectual property protection, and low- and middle-income states demanding equitable access to medicines, technology transfer, and a stronger voice in standard-setting. The COVID-19 pandemic, the 2022 mpox emergency, and ongoing conflicts affecting health systems in Gaza, Sudan, and Ukraine have reinforced that health is inseparable from foreign policy. Debate today centers on how to institutionalize health attachés, integrate health into peace negotiations, and ensure that diplomatic frameworks deliver tangible equity rather than rhetorical solidarity.

Key players

World Health Organization

Global Cooperation for Pandemic Preparedness

Pandemic preparedness rose to the top of the international agenda after the 2014-2016 West African Ebola outbreak revealed gaps in surveillance, financing, and surge response. COVID-19 deepened the urgency: by 2024 it had caused millions of deaths and exposed inequities in vaccine distribution, with high-income countries securing doses far ahead of low-income ones. The WHO's Independent Panel for Pandemic Preparedness and Response, the IHR Review Committee, and the G20 High-Level Independent Panel all called for stronger international architecture, sustained financing, and binding norms on information and countermeasure sharing. These pressures produced two parallel processes: amendments to the 2005 International Health Regulations, adopted in 2024, and the WHO Pandemic Agreement, adopted by the World Health Assembly in May 2025. The Agreement creates a Pathogen Access and Benefit-Sharing (PABS) System, commitments on technology transfer, and a Global Supply Chain and Logistics Network. Implementation, however, remains contested: pharmaceutical-producing states resist mandatory technology transfer, while many developing states view equitable access as the precondition for sharing genetic sequence data. The committee now faces the operational phase. Outstanding issues include the design of the PABS annex, the Pandemic Fund's replenishment, One Health integration covering zoonotic spillover, and how to sustain preparedness investment between crises when political attention wanes.

Key players

World Health Organization

The Role of the WHO in Health Diplomacy

Founded in 1948 as the UN specialized agency for health, the WHO has long served as the principal convening platform where states negotiate norms, share epidemiological intelligence, and coordinate responses to cross-border threats. Its diplomatic role solidified through landmark instruments: the 2003 Framework Convention on Tobacco Control (its first treaty under Article 19), the 2005 International Health Regulations, and the 2011 Pandemic Influenza Preparedness Framework. Through these, WHO positioned itself not merely as a technical agency but as a forum for binding and non-binding diplomacy. The organization's diplomatic authority has nonetheless been tested. COVID-19 brought criticism over the speed of its public health emergency declaration, the independence of its outbreak investigations, and its dependence on voluntary, earmarked contributions that constrain agenda-setting. The 2022 announcement of a sustainable financing model, raising assessed contributions to 50 percent of the core budget by 2030-31, and the 2025 adoption of the Pandemic Agreement represent attempts to restore credibility and capacity. Debate now centers on how the WHO can balance member-state authority with rapid emergency action, manage relationships with non-state funders such as the Gates Foundation, coordinate with regional bodies like Africa CDC, and assert convening power amid geopolitical rivalry. Reforms to its emergencies programme, alert system, and Director-General's investigatory powers remain politically sensitive.

Key players

World Health Organization

Bilateral Health Agreements and Policies

Bilateral health cooperation predates the multilateral system, originating in 19th-century quarantine agreements and colonial-era medical missions. In the post-1945 era, bilateral aid through agencies such as USAID, JICA, GIZ, AFD, and DFID/FCDO became central to disease eradication, primary health care, and health system strengthening. Bilateral instruments are typically more flexible than multilateral treaties and can include memoranda of understanding, joint research programmes, health worker mobility agreements, and procurement deals. The past two decades have seen bilateral health diplomacy diversify. China's Health Silk Road, India's vaccine diplomacy (Vaccine Maitri), Cuba's medical brigades, and Gulf-state health investments operate alongside traditional Western donors. These arrangements support hospital construction, emergency response deployments, regulatory harmonization, and increasingly digital health and AI infrastructure. They also raise questions about conditionality, alignment with national health plans, debt sustainability, and brain drain when wealthier states recruit health workers from countries facing shortages. Current policy debates focus on aligning bilateral deals with the WHO Global Code of Practice on the International Recruitment of Health Personnel, ensuring coherence with multilateral commitments such as the Lusaka Agenda on global health initiatives, and managing geopolitical competition that risks fragmenting recipient countries' health systems. Bilateral agreements on pandemic surveillance, medical countermeasure supply, and regulatory recognition are emerging as new frontiers.

Key players

World Health Organization

Global Health Governance and HIV/AIDS

HIV/AIDS catalysed the modern global health governance architecture. After the virus was identified in the early 1980s, the WHO Global Programme on AIDS (1987) was the first major coordinated international response, later succeeded in 1996 by UNAIDS, a unique joint UN programme designed to integrate the work of multiple agencies. The 2001 UN General Assembly Special Session on HIV/AIDS and its Declaration of Commitment marked the first time the Security Council and General Assembly treated a disease as a matter of international peace and security, prompting the creation of the Global Fund to Fight AIDS, Tuberculosis and Malaria in 2002 and the US PEPFAR programme in 2003. Governance challenges have evolved with the epidemic. Early debates centered on access to antiretroviral therapy, intellectual property under TRIPS, and the Doha Declaration's affirmation of public health flexibilities. Today, governance focuses on sustaining financing as donor fatigue grows, transitioning countries to domestic financing, integrating HIV services into broader primary health care, and addressing inequities affecting key populations, including men who have sex with men, sex workers, people who inject drugs, and adolescent girls in eastern and southern Africa. UNAIDS' 2025 targets aimed at ending AIDS as a public health threat by 2030 are off-track in several regions. Recent funding cuts to PEPFAR and to the Global Fund's replenishment, combined with criminalization laws in some states, raise governance questions about accountability, equity, and the resilience of the multilateral HIV response.

Key players

World Health Organization

Health Diplomacy in the Fight Against HIV/AIDS

HIV/AIDS reshaped health diplomacy more than any other disease. In the late 1990s, the gap between antiretroviral access in wealthy countries and in sub-Saharan Africa, where prevalence exceeded 20 percent in some states, became a defining moral and political issue. Diplomatic battles played out at the WTO over TRIPS, at the UN Security Council with Resolution 1308 (2000) recognizing HIV as a security issue, and through civil society mobilization that pressured pharmaceutical companies to lower prices and permit generic production. The diplomatic toolkit broadened with the creation of the Global Fund, PEPFAR, UNITAID, and the Medicines Patent Pool. South-South diplomacy emerged through Brazil's technical cooperation with African states, India's generic antiretroviral exports, and South Africa's leadership at the WHO and at international AIDS conferences. The 2016 UN Political Declaration on Ending AIDS and the 2021 follow-up declaration set ambitious targets but exposed continued diplomatic tensions over harm reduction, sexual and reproductive health rights, and key population programming. Current diplomacy must navigate shrinking donor commitments, the rollout of long-acting injectables such as lenacapavir and cabotegravir and their pricing, and political backlash in some states against rights-based prevention approaches. Negotiations on the future of PEPFAR, Global Fund replenishment cycles, and integration with pandemic preparedness instruments are central diplomatic frontiers.

Key players

World Health Organization

Multilateralism and the HIV/AIDS Response

The HIV/AIDS response is a textbook case of multilateral innovation. UNAIDS, established in 1996, brought together eleven UN co-sponsoring agencies under a single governance structure, the Programme Coordinating Board, that uniquely includes civil society and people living with HIV as non-voting members. The Global Fund, created in 2002, pioneered a public-private financing partnership with country-led grant-making. UNITAID, founded in 2006 and partly financed by an air-ticket levy, demonstrated innovative financing for commodities. Multilateral instruments have produced measurable results: new HIV infections fell by roughly 60 percent from their 1995 peak, and over 30 million people are now on antiretroviral therapy. Yet the architecture faces strain. Donor fragmentation, parallel vertical programmes, and overlapping mandates have prompted the 2023 Lusaka Agenda for the future of global health initiatives, which calls for stronger country ownership and integration into national systems. Multilateralism in HIV is also tested politically. Negotiations over Political Declarations have repeatedly stalled on language about key populations, comprehensive sexuality education, and harm reduction, with blocs led by socially conservative states resisting rights-based formulations. The committee must consider how to preserve the unique multilateral architecture built around HIV while adapting it to a constrained financing environment and to integration with pandemic and primary health care agendas.

Key players

World Health Organization

Policy Advocacy for HIV/AIDS Prevention and Treatment

Policy advocacy has driven nearly every major advance in the HIV response. From ACT UP's mobilization in the 1980s to the Treatment Action Campaign's litigation in South Africa in the early 2000s, civil society pressure repeatedly translated scientific possibility into political commitment. Advocacy secured the inclusion of antiretroviral therapy in WHO essential medicines lists, the price reductions that made treatment affordable in low-income countries, and the recognition of U=U (undetectable equals untransmittable) as a public health and human rights principle. Prevention advocacy has had to navigate complex politics. The expansion of pre-exposure prophylaxis (PrEP), voluntary medical male circumcision, harm reduction services, and comprehensive sexuality education has met resistance in states where laws criminalize same-sex conduct, sex work, or drug use, undermining access. The 2024 approval of twice-yearly lenacapavir for PrEP offers a transformative tool, but pricing, voluntary licensing, and rapid generic introduction are now central advocacy battlegrounds, much as antiretrovirals were in the 2000s. The committee must address how international policy can support evidence-based prevention and treatment in the face of legal and social barriers, ensure community-led responses remain financed, and protect data and human rights in digital health and surveillance systems. With funding uncertainty for PEPFAR and the Global Fund, advocacy for sustainable domestic financing and equitable access to next-generation tools is more consequential than ever.

Key players

Resources

News, lessons, and country profiles to prep for International Conference on International Cooperation, Health Diplomacy, and Policy.

Recent reporting to ground your prep

Trump's Economic Reset

Mifepristone Ruling Sparks 2026 Political Tug

GOP Promotes Trump's Tax Savings on Deadline

Howard Lutnick's Senate Testimony on 2027 Bud

Lessons

Bite-sized lessons to build the basics

Hidden Stakeholders

Engagement Strategies

Dynamic Analysis

Stakeholder Mapping Workshop

Courses

Guided courses that go deeper on the topic

Multilateral Negotiation

Policy Brief Writing

Media & Press Relations

Advanced Negotiation

The states in play, with the data that shapes their stance

Country dossier

Country dossier

Country dossier

Country dossier

Country dossier

Country dossier

Country dossier

Country dossier

Country dossier

Country dossier

Country dossier

Country dossier

Country dossier

Country dossier

Country dossier

Country dossier

Country dossier

Country dossier

By committee

Frequently asked questions

International Conference on International Cooperation, Health Diplomacy, and Policy

Nov 21, 2026Cairo, EgyptIn-person

Registration open

Committees & topics

World Health Organization
Health Diplomacy in International Relations · Global Cooperation for Pandemic Preparedness · The Role of the WHO in Health Diplomacy · Bilateral Health Agreements and Policies · Global Health Governance and HIV/AIDS · Health Diplomacy in the Fight Against HIV/AIDS · Multilateralism and the HIV/AIDS Response · Policy Advocacy for HIV/AIDS Prevention and Treatment

Why it matters

How to prepare

Country perspectives

Where the most-relevant 4 countries stand on the core issues in play. Click through for the full country profile.

Egypt

As the host nation, EGY is likely to emphasize regional health challenges and the importance of South-South cooperation in health diplomacy.

Role in topic

United States

The USA will likely advocate for robust global health security frameworks and emphasize its contributions to international health funding and research.

Role in topic

China

CHN is expected to highlight its Belt and Road Initiative's health component and its contributions to global health through medical aid and infrastructure development.

Role in topic

Switzerland

CHE will likely stress its role as a hub for international organizations and its commitment to humanitarian health aid and neutral mediation in health crises.

Role in topic